Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5results about How to "Easy to inactivate" patented technology

Zika virus vaccine

ActiveSI3393510T2mass productionEasy to inactivate
Described herein are Zika virus vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.
Owner:VALNEVA AUSTRIA GMBH

Application of CoNi / C composite material in chlorofluoroalkane dehydrochlorination reaction

The invention relates to the technical field of chemical catalysts, and provides an application of a CoNi / C composite material in a chlorofluoroalkane dehydrochlorination reaction, and a preparation method of the CoNi / C composite material comprises the step of contacting a cobalt source, a nickel source and a carbon source to obtain the CoNi / C composite material. The CoNi / C composite material can be used as a catalyst for a dehydrochlorination reaction of chlorofluoroalkanes, so that the problem that the catalyst is inactivated due to the phenomena of carbon deposition and easy sintering of the existing catalyst is solved.
Owner:RUYUAN DONGYANG LIGHT FLUORIDE CO LTD +1

Zika virus vaccine

ActiveFI3393510T4mass productionEasy to inactivate
Owner:VALNEVA AUSTRIA GMBH

ZIKA VIRUS VACCINE

ActiveDK3393510T4mass productionEasy to inactivate
Owner:VALNEVA AUSTRIA GMBH

A method for extracting mycobacterium genome

The present invention provides a method for extracting a mycobacterium genome, and belongs to the field of biological detection technology. The method for extracting the mycobacterium genome provided by the present invention uses lysase LysA and LysB for wall breaking treatment, which solves the problem of poor mycobacterium genome extraction effect in the prior art. The total genome amount of Mycobacterium tuberculosis extracted by the present invention can reach about 5-10 times that of the traditional classical CTAB genome extraction method, and the integrity of the obtained genome fragments is significantly improved. Compared with the use of lysozyme overnight treatment in the traditional CTAB genome extraction method, the LysA and LysB treatment in the present invention for 2 hours can achieve several times the extraction efficiency, greatly shortening the extraction time, being superior to the traditional CTAB genome extraction method and the genome extraction kit on the market, and being conducive to the rapid and efficient extraction of complete mycobacterium genomes in clinical and laboratory settings.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV